Cargando…
Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’
BACKGROUND: Vitamin D enhances host protective immune responses to Mycobacterium tuberculosis by suppressing Interferon-gamma (IFN-g) and reducing disease associated inflammation in the host. The objectives of this study were to determine whether vitamin D supplementation to patients with tuberculos...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556334/ https://www.ncbi.nlm.nih.gov/pubmed/23331510 http://dx.doi.org/10.1186/1471-2334-13-22 |
_version_ | 1782257173787574272 |
---|---|
author | Salahuddin, Nawal Ali, Farheen Hasan, Zahra Rao, Nisar Aqeel, Masooma Mahmood, Faisal |
author_facet | Salahuddin, Nawal Ali, Farheen Hasan, Zahra Rao, Nisar Aqeel, Masooma Mahmood, Faisal |
author_sort | Salahuddin, Nawal |
collection | PubMed |
description | BACKGROUND: Vitamin D enhances host protective immune responses to Mycobacterium tuberculosis by suppressing Interferon-gamma (IFN-g) and reducing disease associated inflammation in the host. The objectives of this study were to determine whether vitamin D supplementation to patients with tuberculosis (TB) could influence recovery. METHODS: Two hundred and fifty nine patients with pulmonary TB were randomized to receive either 600,000 IU of Intramuscular vitamin D(3) or placebo for 2 doses. Assessments were performed at 4, 8 and 12 weeks. Early secreted and T cell activated 6 kDa (ESAT6) and Mycobacterium tuberculosis sonicate (MTBs) antigen induced whole blood stimulated IFN-g responses were measured at 0 and 12 weeks. Statistical comparisons between outcome variables at 0 and 12 weeks were performed using Student’s t-test and Chi(2) tests. RESULTS: After 12 weeks, the vitamin D supplemented arm demonstrated significantly greater mean weight gain (kg) + 3.75, (3.16 – 4.34) versus + 2.61 (95% CI 1.99 – 3.23) p 0.009 and lesser residual disease by chest radiograph; number of zones involved 1.35 v/s 1.82 p 0.004 (95% CI 0.15, 0.79) and 50% or greater reduction in cavity size 106 (89.8%) v/s 111 (94.8%), p 0.035. Vitamin D supplementation led to significant increase in MTBs-induced IFN-g secretion in patients with baseline ‘Deficient’ 25-hydroxyvitamin D serum levels (p 0.021). CONCLUSIONS: Supplementation with high doses of vitamin D accelerated clinical, radiographic improvement in all TB patients and increased host immune activation in patients with baseline ‘Deficient’ serum vitamin D levels. These results suggest a therapeutic role for vitamin D in the treatment of TB. TRIAL REGISTRATION: ClinicalTrials.gov; No. NCT01130311; URL: clinicaltrials.gov |
format | Online Article Text |
id | pubmed-3556334 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35563342013-01-30 Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’ Salahuddin, Nawal Ali, Farheen Hasan, Zahra Rao, Nisar Aqeel, Masooma Mahmood, Faisal BMC Infect Dis Research Article BACKGROUND: Vitamin D enhances host protective immune responses to Mycobacterium tuberculosis by suppressing Interferon-gamma (IFN-g) and reducing disease associated inflammation in the host. The objectives of this study were to determine whether vitamin D supplementation to patients with tuberculosis (TB) could influence recovery. METHODS: Two hundred and fifty nine patients with pulmonary TB were randomized to receive either 600,000 IU of Intramuscular vitamin D(3) or placebo for 2 doses. Assessments were performed at 4, 8 and 12 weeks. Early secreted and T cell activated 6 kDa (ESAT6) and Mycobacterium tuberculosis sonicate (MTBs) antigen induced whole blood stimulated IFN-g responses were measured at 0 and 12 weeks. Statistical comparisons between outcome variables at 0 and 12 weeks were performed using Student’s t-test and Chi(2) tests. RESULTS: After 12 weeks, the vitamin D supplemented arm demonstrated significantly greater mean weight gain (kg) + 3.75, (3.16 – 4.34) versus + 2.61 (95% CI 1.99 – 3.23) p 0.009 and lesser residual disease by chest radiograph; number of zones involved 1.35 v/s 1.82 p 0.004 (95% CI 0.15, 0.79) and 50% or greater reduction in cavity size 106 (89.8%) v/s 111 (94.8%), p 0.035. Vitamin D supplementation led to significant increase in MTBs-induced IFN-g secretion in patients with baseline ‘Deficient’ 25-hydroxyvitamin D serum levels (p 0.021). CONCLUSIONS: Supplementation with high doses of vitamin D accelerated clinical, radiographic improvement in all TB patients and increased host immune activation in patients with baseline ‘Deficient’ serum vitamin D levels. These results suggest a therapeutic role for vitamin D in the treatment of TB. TRIAL REGISTRATION: ClinicalTrials.gov; No. NCT01130311; URL: clinicaltrials.gov BioMed Central 2013-01-19 /pmc/articles/PMC3556334/ /pubmed/23331510 http://dx.doi.org/10.1186/1471-2334-13-22 Text en Copyright ©2013 Salahuddin et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Salahuddin, Nawal Ali, Farheen Hasan, Zahra Rao, Nisar Aqeel, Masooma Mahmood, Faisal Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’ |
title | Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’ |
title_full | Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’ |
title_fullStr | Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’ |
title_full_unstemmed | Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’ |
title_short | Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis’ |
title_sort | vitamin d accelerates clinical recovery from tuberculosis: results of the succinct study [supplementary cholecalciferol in recovery from tuberculosis]. a randomized, placebo-controlled, clinical trial of vitamin d supplementation in patients with pulmonary tuberculosis’ |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556334/ https://www.ncbi.nlm.nih.gov/pubmed/23331510 http://dx.doi.org/10.1186/1471-2334-13-22 |
work_keys_str_mv | AT salahuddinnawal vitamindacceleratesclinicalrecoveryfromtuberculosisresultsofthesuccinctstudysupplementarycholecalciferolinrecoveryfromtuberculosisarandomizedplacebocontrolledclinicaltrialofvitamindsupplementationinpatientswithpulmonarytuberculosis AT alifarheen vitamindacceleratesclinicalrecoveryfromtuberculosisresultsofthesuccinctstudysupplementarycholecalciferolinrecoveryfromtuberculosisarandomizedplacebocontrolledclinicaltrialofvitamindsupplementationinpatientswithpulmonarytuberculosis AT hasanzahra vitamindacceleratesclinicalrecoveryfromtuberculosisresultsofthesuccinctstudysupplementarycholecalciferolinrecoveryfromtuberculosisarandomizedplacebocontrolledclinicaltrialofvitamindsupplementationinpatientswithpulmonarytuberculosis AT raonisar vitamindacceleratesclinicalrecoveryfromtuberculosisresultsofthesuccinctstudysupplementarycholecalciferolinrecoveryfromtuberculosisarandomizedplacebocontrolledclinicaltrialofvitamindsupplementationinpatientswithpulmonarytuberculosis AT aqeelmasooma vitamindacceleratesclinicalrecoveryfromtuberculosisresultsofthesuccinctstudysupplementarycholecalciferolinrecoveryfromtuberculosisarandomizedplacebocontrolledclinicaltrialofvitamindsupplementationinpatientswithpulmonarytuberculosis AT mahmoodfaisal vitamindacceleratesclinicalrecoveryfromtuberculosisresultsofthesuccinctstudysupplementarycholecalciferolinrecoveryfromtuberculosisarandomizedplacebocontrolledclinicaltrialofvitamindsupplementationinpatientswithpulmonarytuberculosis |